Le cerebral artery occlusion model. J Pharmacol Exp Ther 281:921?27 5. Watanabe T, Yuki S, Egawa M, Nishi H (1984) Protective effects of MCI-186 on cerebral ischemia: doable involvement of cost-free radical scavenging and antioxidant actions. J Pharmacol Exp Ther 268:1597?604 six. Wu TW, Zeng LH, Wu J, Fung KP (2002) Myocardial protection of MCI-186 in rabbit ischemia-reperfusion. Life Sci 71:2249?255 7. Barba O, Jones LH (2004) Pyrazole derivatives as reverse transcriptase inhibitors.. WO Patent 029042 A1, 8 Apr 2004 8. Plath P, Rohr W, Wuerzer B (1980) Herbicides containing 3-aryl-5methylpyrazole-4-carboxylic acid esters. Ger Offen. DE 2920933 A1 1801204, four Dec 1980 9. Cativiela C, Serrano JL, Zurbano MM (1995) Synthesis of 3-substituted pentene-2,4-diones: precious intermediates for liquid crystals. J Org Chem 60:3074?083 ten. Sugiura S, Ohno S, Ohtani O, Izumi K, Kitamikado T, Asai H, Kato K, Hori M, Fujimura H (1977) Synthesis and antiinflammatory and hypnotic activity of 5-alkoxy-3-(N-substituted carbomoyl)-1-phenyl pyrazoles. J Med Chem 20:80?5 11. Sabaa MW, Oraby FH, Abdel-Naby AS, Mohamed RR (2006) Organic thermal stabilizers for rigid poly(vinylchloride).(S)-3-Bromo-2-(1-methoxyethyl)pyridine Chemical name Aspect XII: N-phenyl-3-substituted-5pyrazolone derivatives. Polym Degrad Stab 91:911?23 12. Kendall JD, Duffin GF (1955) Production of 3-pyrazolidones. US Patent: 2,704,762. Chem Abstr 50:2680f 13. Reynolds GA (1955) Photographic developer composition. US Patent: two,688,548. Chem Abstr 49:596 14. Johnson MP, Moody CJ (1985) Azodienophiles. Diels-Alder reactions of 4-phenyl-1,2,4-triazole-3,5-dione and 5-phenylpyrazole-3-one with functionalised diones. J Chem Soc Perkin Trans 1:71?4 15. Hiremath SP, Saundane AR, Mruthyunjayaswamy BHM (1993) A new system for the synthesis of 6H,11H-indolo[3,2-c]-isoquinolin-5-ones/thiones and their reactions.4-Nitrobutan-1-ol Price J Heterocycl Chem 30:603?09 16.PMID:24103058 Duffy KJ, Darcy MG, Delorme E, Dillon SB, Eppley DF, Miller CE, Giampa L, Hopson CB, Huang Y, Keenan RM, Lamb P, Leong L, Liu N, Miller SG, Value AT, Rosen J, Shaw TN, Smith H, Stark KC, Tain SS, Tyree C, Wiggall KJ, Zhang L, Luengo JI (2001) Hydrazinonapthalene and azonapthalene thrombopoietin mimics are nonpeptidyl promoters of megakaryocytopoiesis. J Med Chem 44:3730?745 17. Jonathan FM, David JB, Kelvin C, John PM, Mark HS (1995) Novel antagonists of platelet-activating factor. two. Synthesis and structure-activity relationships of potent and long-acting heterofused[1,5]benzodiazepine and [1,4]diazepine derivatives of 1-phenyl-2-methyl imidazo[4,5-c]pyridine. J Med Chem 38:3524?535 18. Darin EK, Miller RB, Mark JK (1999) Fused pyrazoloheterocycles: intramolecular [3 + 2]-nitrile oxide cycloadditions applied to syntheses of pyrazolo [3,4-g] [2,1] dihydrobenzoisoxazol(in)es. Tetrahedron Lett 40:3535?538 19. Janja M, Vinko S (1995) Preparation of homologous pyrazolonedicarboxylates. Heterocycles 41:1207?20. Tietze LF, Steinmetz A (1996) A common and expedient system for the solid-phase synthesis of structurally diverse 1-phenylpyrazolone derivatives. Synlett:667?68 21. Kuo S, Huang L, Nakamura K (1984) Research on heterocyclic compounds. six. Synthesis and analgesic and anti-inflammatory activities of 3,4-dimethylpyrano[2,3-c] pyrazol-6-one. J Med Chem 27:539?44 22. Boeckman RK, Jr, Reed JE, Ge P (2001) A novel route to 2,3-pyrazol-1 (5H)-ones by means of palladium-catalyzed carbonylation of 1,2-diaza-1,3-butadienes. Org Lett three:3651?653 23. Hans N, Gernot K, Juergen DH (1985) Hydrazidine, IV. Reaktion von Hydrazidinenmit 1,2-bi.